1887

Chapter 30 : Effects of Quinolones on the Immune System

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in
Zoomout

Effects of Quinolones on the Immune System, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555817817/9781555812317_Chap30-1.gif /docserver/preview/fulltext/10.1128/9781555817817/9781555812317_Chap30-2.gif

Abstract:

The immune system consists of a complex network of innate and adaptive host responses that defend the host against microbial invaders and the development of neoplastic processes. For several decades there has been considerable interest mounting in the effects of antimicrobial agents on components of the immune system. Some of the extensive review articles that have covered the subject during the past two decades are summarized in this chapter. There are at least five mechanisms by which antimicrobial agents can affect the host-pathogen relationship besides a direct bacteriostatic/bactericidal effect on the microbe. Dalhoff has written a detailed review that includes a comprehensive summary of the reported effects of antimicrobial agents on eukaryotic cells. It was successful in significantly preventing systemic or bacteremic infection, thus validating the in vitro observations published. Comparator agents such as clindamycin had no effect on humoral or cellular responses, and cefotaxime, mezlocillin, and amikacin had modest suppressive effects. The explosion in knowledge about immune responses is related, in part, to a better understanding of the complex molecular signals generated when secretory cells of the reticuloendothelial system, particularly monocytes and macrophages, have been studied for cytokine generation. A plethora of quinolone effects on specific components of the immune response have been reviewed. Downregulation of cytokine responses has also been noted for other antimicrobial agents, including macrolides.

Citation: Young L. 2003. Effects of Quinolones on the Immune System, p 467-473. In Hooper D, Rubinstein E (ed), Quinolone Antimicrobial Agents, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817817.ch30
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555817817.chap30
1. Bermudez, L. E.,, L. S. Young,, and C. B. Inderlied. 1994. Rifabutin and sparfloxacin but not azithromycin inhibit binding of Mycobacterium avium complex to HT-29 intestinal mucosal cells. Antimicrob. Agents Chemother. 38:12001202.
2. Boogaerts, M. A.,, S. Malbrain,, W. Scheers,, and R. L. Verwilghen. 1986. Effects of quinolones on granulocyte function in vitro. Infection 4:258262.
3. Cuffini, A. M.,, V. Tullio,, A. Allocco,, G. Paizis,, C. De Leo,, and N. A. Carlone. 1994. Effect of rufloxacin upon non-specific immune defences: in-vitro, ex-vivo and in-vivo results. J. Antimicrob. Chemother. 34:545553.
4. Dalhoff, A., 1998. Interaction of quinolones with host-parasite relationship, p. 233257. In J. Kuhlmann,, A. Dalhoff,, and H.-J. Zeiler (ed.), Handbook of Experimental Pharmacology, vol. 127. Springer-Verlag, Berlin, Germany.
5. Forsgren, A.,, and P. I. Bergkvist. 1985. Effect of ciprofloxacin on phagocytosis. Eur. J. Clin. Microbiol. 4:575578.
6. Forsgren, A.,, S. F. Schlossman,, and T. F. Tedder. 1987. 4-Quinolone drugs affect cell cycle progression and function of human lymphocytes in vitro. Antimicrob. Agents Chemother. 31:768773.
7. Gollapudi, S. V.,, R. H. Prabhala,, and H. Thadepalli. 1986. Effect of ciprofloxacin on mitogen-stimulated lymphocyte proliferation. Antimicrob. Agents Chemother. 29:337338.
8. Hauser, W. E.,, and J. S. Remington. 1982. Effect of antibiotics on the immune response. Am. J. Med. 72:711716.
9. Ichiyama, T.,, M. Nishikawa,, T. Yoshitomi,, S. Hasegawa,, T. Matsubara,, T. Hayashi,, and S. Furukawa. 2001. Clarithromycin inhibits NF-kappaB activation in human peripheral blood mononuclear cells and pulmonary epithelial cells. Antimicrob. Agents Chemother. 45:4447.
10. Jackson, J. J.,, and H. Kropp. 1992. beta-Lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime. J. Infect. Dis. 165:10331041.
11. Jimenez-Valera, M.,, A. Sampedro,, E. Moreno,, and A. Ruiz-Bravo. 1995. Modification of immune response in mice by ciprofloxacin. Antimicrob. Agents Chemother. 39:150154.
12. Khan, A. A.,, T. R. Slifer,, F. G. Araujo,, and J. S. Remington. 1999. Effect of clarithromycin and azithromycin on production of cytokines by human monocytes. Int. J. Antimicrob. Agents 11:121132.
13. Khan, A. A.,, T. R. Slifer,, F. G. Araujo,, Y. Suzuki,, and J. S. Remington. 2000. Protection against lipopolysaccharide-induced death by fluoroquinolones. Antimicrob. Agents Chemother. 44:31693173.
14. Khan, A. A.,, T. R. Slifer,, and J. S. Remington. 1998. Effect of trovafloxacin on production of cytokines by human monocytes. Antimicrob. Agents Chemother. 42:17131717.
15. Korzeniowski, O. M. 1989. Effects of antibiotics on the mammalian immune system. Infect. Dis. Clin. N. Am. 3:469478.
16. Labro, M. T. 2000. Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"? Clin. Microbiol. Rev. 13:615650.
17. Morikawa, K.,, F. Oseko,, S. Morikawa,, and K. Iwamoto. 1994. Immunomodulatory effects of three macrolides, midecamycin acetate, josamycin, and clarithromycin, on human Tlymphocyte function in vitro. Antimicrob. Agents Chemother. 38:26432647.
18. Morikawa, K.,, H. Watabe,, M. Araake,, and S. Morikawa. 1996. Modulatory effect of antibiotics on cytokine production by human monocytes in vitro. Antimicrob. Agents Chemother. 40:13661370.
19. Nau, R.,, G. Zysk,, H. Schmidt,, F. R. Fischer,, A. K. Stringaris,, K. Stuertz,, and W. Brack. 1997. Trovafloxacin delays the antibiotic-induced inflammatory response in experimental pneumococcal meningitis J. Antimicrob. Chemother. 39:781788.
20. Nitsche, D.,, C. Schulze,, S. Oesser,, A. Dalhoff,, and M. Sack. 1996. Impact of different classes antimicrobial agents on plasma endotoxin activity. Arch. Surg. 131:192199.
21. Ono, Y.,, Y. Ohmoto,, K. Ono,, Y. Sakata,, and K. Murata. 2000. Effect of grepafloxacin on cytokine production in vitro. J. Antimicrob. Chemother. 46:9194.
22. Prins, J. M.,, E. J. Kuijper,, M. L. Mevissen,, P. Speelman,, and S. J. van Deventer. 1995. Release of tumor necrosis factor alpha and interleukin 6 during antibiotic killing of Escherichia coli in whole blood: influence of antibiotic class, antibiotic concentration, and presence of septic serum. Infect. Immun. 63:22362242.
23. Prins, J. M.,, M. A. van Agtmael,, E. J. Kuijper,, S. J. van Deventer,, and P. Speelman. 1995. Antibiotic-induced endotoxin release in patients with gram-negative urosepsis: a double- blind study comparing imipenem and ceftazidime. J. Infect. Dis. 172:886891.
24. Riesbeck, K.,, J. Andersson,, M. Gullberg,, and A. Forsgren. 1989. Fluorinated 4-quinolones induce hyperproduction of interleukin 2. Proc. Natl. Acad. Sci. USA. 86:28092813.
25. Roszkowski, W.,, H. L. Ko,, K. Roszkowski,, P. Ciborowski,, J. Jeljaszewicz,, and G. Pulverer. 1986. Effects of ciprofloxacin on the humoral and cellular immune responses in Balb/c-mice. Zentbl. Bakteriol. Mikrobiol. Hyg. Ser. A 262:396402.
26. Rubinstein, E.,, and I. Shalit,. 1993. Effects of the quinolones on the immune system, p. 519526. In D. C. Hooper, and J. S. Wolfson (ed.), Quinolone Antimicrobial Agents, 2nd ed. American Society for Microbiology, Washington, D.C..
27. Schmidt, H.,, A. Dalhoff,, K. Stuertz,, F. Trostdorf,, V. Chen,, O. Schneider,, C. Kohlsdorfer,, W. Brack,, and R. Nau. 1998. Moxifloxacin in the therapy of experimental pneumococcal meningitis. Antimicrob. Agents Chemother. 42:13971407.
28. Simpson, A. J.,, S. M. Opal,, B. J. Angus,, J. M. Prins,, J. E. Palardy,, N. A. Parejo,, W. Chaowagul,, and N. J. White. 2000. Differential antibiotic-induced endotoxin release in severe melioidosis. J Infect. Dis. 181:10141019.
29. Somekh, E.,, S. West,, A. Barzilai,, and E. Rubinstein. 1989. The lack of long-term suppressive effect of ciprofloxacin on murine bone marrow. J. Antimicrob. Chemother. 24:209213.
30. Stevens, D. L. 1996. Immune modulatory effects of antibotics. Curr. Opin. Infect. Dis. 9:165169.
31. Stevens, D. L.,, A. E. Bryant,, and S. P. Hackett. 1995. Antibiotic effects on bacterial viability, toxin production, and host response. Clin. Infect. Dis. 20(Suppl. 2):S154S157.
32. Stuertz, K.,, H. Schmidt,, H. Eiffert,, P. Schwartz,, M. Mader,, and R. Nau. 1998. Differential release of lipoteichoic and teichoic acids from Streptococcus pneumoniae as a result of exposure to beta-lactam antibiotics, rifamycins, trovafloxacin, and quinupristin-dalfopristin. Antimicrob. Agents Chemother. 42:277281.
33. Tuomanen, E.,, H. Liu,, B. Hengstler,, O. Zak,, and A. Tomasz. 1985. The induction of meningeal inflammation by components of the pneumococcal cell wall. J. Infect. Dis. 151:859868.
34. van Langevelde, P.,, J. T. van Dissel,, E. Ravensbergen,, B. J. Appelmelk,, I. A. Schrijver,, and P. H. Groeneveld. 1998. Antibiotic-induced release of lipoteichoic acid and peptidoglycan from Staphylococcus aureus: quantitative measurements and biological reactivities. Antimicrob. Agents Chemother. 42:30733078.
35. Van Vlem, B.,, R. Vanholder,, P. De Paepe,, D. Vogelaers,, and S. Ringoir. 1996. Immunomodulating effects of antibiotics: literature review. Infection 24:275291.
36. Yokokawa, K.,, R. Mankus,, M. G. Saklayen,, M. Kohno,, K. Yasunari,, M. Minami,, H. Kano,, T. Horio,, T. Takeda,, and A. K. Mandel. 1995. Increased nitric oxide production in patients with hypotension during hemodialysis. Ann. Intern. Med. 123:3537.
37. Young, L. S.,, M. Wu,, and J. Bender. 1992. Pilot study of sparfloxacin for M. avium complex bacteremia complicating AIDS. In Program and Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherpy. American Society for Microbiology, Washington, D.C..

Tables

Generic image for table
Table 1

General reviews of the effects of antimicrobial agents on immune responses

Citation: Young L. 2003. Effects of Quinolones on the Immune System, p 467-473. In Hooper D, Rubinstein E (ed), Quinolone Antimicrobial Agents, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817817.ch30
Generic image for table
Table 2

Five mechanisms by which antibiotics affect host-parasite relationships besides bactericidal/static properties

Citation: Young L. 2003. Effects of Quinolones on the Immune System, p 467-473. In Hooper D, Rubinstein E (ed), Quinolone Antimicrobial Agents, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817817.ch30
Generic image for table
Table 3

A quinolone, sparfloxacin, blocks binding of complex organisms to HT-19 intestinal mucosal cells

Citation: Young L. 2003. Effects of Quinolones on the Immune System, p 467-473. In Hooper D, Rubinstein E (ed), Quinolone Antimicrobial Agents, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817817.ch30
Generic image for table
Table 4

Effect of components of innate and acquired immunity

Citation: Young L. 2003. Effects of Quinolones on the Immune System, p 467-473. In Hooper D, Rubinstein E (ed), Quinolone Antimicrobial Agents, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817817.ch30
Generic image for table
Table 5

0111:B4 challenge of 1 mg LPS (LD)

Citation: Young L. 2003. Effects of Quinolones on the Immune System, p 467-473. In Hooper D, Rubinstein E (ed), Quinolone Antimicrobial Agents, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817817.ch30

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error